| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Metagenomics | 6 | 2020 | 823 | 1.73 | Why? |
| Drug Resistance | 5 | 2018 | 395 | 1.42 | Why? |
| Plasmodium falciparum | 3 | 2018 | 337 | 1.22 | Why? |
| Boidae | 2 | 2018 | 25 | 0.89 | Why? |
| Arenaviridae | 2 | 2018 | 37 | 0.89 | Why? |
| Genome, Protozoan | 2 | 2017 | 11 | 0.88 | Why? |
| Protozoan Proteins | 2 | 2018 | 205 | 0.84 | Why? |
| Sequence Analysis, DNA | 9 | 2017 | 2830 | 0.81 | Why? |
| Metagenome | 2 | 2020 | 268 | 0.77 | Why? |
| Passeriformes | 1 | 2018 | 14 | 0.76 | Why? |
| Arenaviridae Infections | 2 | 2018 | 43 | 0.73 | Why? |
| Genetic Techniques | 3 | 2009 | 79 | 0.72 | Why? |
| Bunyamwera virus | 1 | 2017 | 1 | 0.72 | Why? |
| Cloud Computing | 1 | 2020 | 214 | 0.72 | Why? |
| H(+)-K(+)-Exchanging ATPase | 1 | 2017 | 3 | 0.71 | Why? |
| Eye Infections, Parasitic | 1 | 2017 | 9 | 0.70 | Why? |
| Picornaviridae | 1 | 2018 | 123 | 0.70 | Why? |
| Genome | 2 | 2017 | 341 | 0.69 | Why? |
| APOBEC Deaminases | 1 | 2017 | 58 | 0.68 | Why? |
| DNA, Protozoan | 1 | 2017 | 77 | 0.68 | Why? |
| Groundwater | 1 | 2017 | 45 | 0.66 | Why? |
| Antimalarials | 3 | 2018 | 2505 | 0.66 | Why? |
| Nitrates | 1 | 2017 | 98 | 0.65 | Why? |
| Bird Diseases | 1 | 2018 | 130 | 0.65 | Why? |
| Isoquinolines | 1 | 2017 | 69 | 0.65 | Why? |
| Plasmodium | 1 | 2017 | 74 | 0.64 | Why? |
| Oligonucleotide Array Sequence Analysis | 7 | 2011 | 343 | 0.62 | Why? |
| Meningoencephalitis | 1 | 2017 | 208 | 0.55 | Why? |
| Protein Biosynthesis | 1 | 2018 | 653 | 0.54 | Why? |
| Uveitis | 1 | 2017 | 233 | 0.54 | Why? |
| Clinical Laboratory Services | 1 | 2020 | 781 | 0.52 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.52 | Why? |
| DNA, Viral | 3 | 2017 | 2521 | 0.51 | Why? |
| Agriculture | 1 | 2017 | 367 | 0.51 | Why? |
| Autoantibodies | 2 | 2021 | 2094 | 0.50 | Why? |
| Encephalitis, Viral | 1 | 2017 | 355 | 0.49 | Why? |
| Picornaviridae Infections | 1 | 2018 | 544 | 0.49 | Why? |
| Virology | 3 | 2012 | 489 | 0.48 | Why? |
| Genes, Viral | 2 | 2009 | 1428 | 0.44 | Why? |
| Interferon Type I | 2 | 2021 | 2789 | 0.43 | Why? |
| Fever of Unknown Origin | 1 | 2012 | 93 | 0.43 | Why? |
| Software | 4 | 2020 | 2501 | 0.40 | Why? |
| CRISPR-Cas Systems | 3 | 2020 | 1397 | 0.40 | Why? |
| Eye Infections, Viral | 1 | 2017 | 517 | 0.39 | Why? |
| High-Throughput Nucleotide Sequencing | 5 | 2020 | 3633 | 0.39 | Why? |
| Mutation | 4 | 2017 | 12376 | 0.37 | Why? |
| Carcinoma, Squamous Cell | 1 | 2017 | 902 | 0.37 | Why? |
| Point-of-Care Testing | 2 | 2021 | 2782 | 0.37 | Why? |
| Viral Load | 5 | 2021 | 15850 | 0.36 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.32 | Why? |
| Exome | 2 | 2017 | 207 | 0.30 | Why? |
| California | 3 | 2021 | 2047 | 0.29 | Why? |
| Malaria, Falciparum | 3 | 2018 | 377 | 0.28 | Why? |
| Head and Neck Neoplasms | 1 | 2017 | 1568 | 0.28 | Why? |
| Genetic Variation | 2 | 2017 | 3919 | 0.28 | Why? |
| Nasopharynx | 4 | 2021 | 10224 | 0.26 | Why? |
| Disease Susceptibility | 1 | 2017 | 4002 | 0.26 | Why? |
| RNA, Viral | 7 | 2021 | 32276 | 0.23 | Why? |
| San Francisco | 2 | 2022 | 711 | 0.23 | Why? |
| Virus Diseases | 4 | 2012 | 3779 | 0.22 | Why? |
| Viruses | 2 | 2012 | 2238 | 0.22 | Why? |
| Nucleic Acid Hybridization | 4 | 2011 | 140 | 0.21 | Why? |
| Brain | 1 | 2017 | 5133 | 0.20 | Why? |
| Zolazepam | 1 | 2018 | 1 | 0.20 | Why? |
| Tiletamine | 1 | 2018 | 1 | 0.20 | Why? |
| Mefloquine | 1 | 2018 | 39 | 0.19 | Why? |
| Beak | 1 | 2018 | 1 | 0.19 | Why? |
| Drug Resistance, Multiple, Fungal | 1 | 2019 | 45 | 0.19 | Why? |
| Optical Imaging | 1 | 2020 | 197 | 0.19 | Why? |
| Intraocular Lymphoma | 1 | 2017 | 3 | 0.18 | Why? |
| Strigiformes | 1 | 2017 | 4 | 0.18 | Why? |
| Fluorides, Topical | 1 | 2017 | 13 | 0.18 | Why? |
| Silver Compounds | 1 | 2017 | 18 | 0.18 | Why? |
| Immobilization | 1 | 2018 | 74 | 0.18 | Why? |
| Midazolam | 1 | 2018 | 79 | 0.18 | Why? |
| Toxoplasmosis, Ocular | 1 | 2017 | 5 | 0.18 | Why? |
| Animal Structures | 1 | 2017 | 61 | 0.18 | Why? |
| DNA, Neoplasm | 1 | 2017 | 56 | 0.18 | Why? |
| Ciliophora | 1 | 2017 | 2 | 0.18 | Why? |
| Cleavage And Polyadenylation Specificity Factor | 1 | 2017 | 6 | 0.18 | Why? |
| Herpes Zoster Ophthalmicus | 1 | 2017 | 17 | 0.18 | Why? |
| Neurofibroma | 1 | 2017 | 1 | 0.18 | Why? |
| Genes, Neurofibromatosis 1 | 1 | 2017 | 3 | 0.17 | Why? |
| Neurofibromin 1 | 1 | 2017 | 4 | 0.17 | Why? |
| Spliceosomes | 1 | 2017 | 15 | 0.17 | Why? |
| Orchitis | 1 | 2018 | 82 | 0.17 | Why? |
| Germ Cells | 1 | 2017 | 39 | 0.17 | Why? |
| Foot-and-Mouth Disease Virus | 1 | 2017 | 29 | 0.17 | Why? |
| Encephalitis Viruses, Tick-Borne | 1 | 2018 | 100 | 0.17 | Why? |
| Myeloid Differentiation Factor 88 | 1 | 2017 | 109 | 0.17 | Why? |
| Endopeptidases | 2 | 2017 | 228 | 0.17 | Why? |
| Toxoplasma | 1 | 2017 | 61 | 0.17 | Why? |
| Cytoplasm | 1 | 2018 | 304 | 0.17 | Why? |
| Neurofibromatosis 1 | 1 | 2017 | 19 | 0.17 | Why? |
| Introns | 1 | 2017 | 112 | 0.17 | Why? |
| Ribosomes | 1 | 2018 | 200 | 0.17 | Why? |
| Aqueous Humor | 1 | 2017 | 82 | 0.17 | Why? |
| Encephalitis, Tick-Borne | 1 | 2018 | 86 | 0.17 | Why? |
| Gene Expression Regulation, Bacterial | 1 | 2017 | 143 | 0.17 | Why? |
| RNA Editing | 1 | 2017 | 80 | 0.16 | Why? |
| Simplexvirus | 1 | 2017 | 124 | 0.16 | Why? |
| Boron Compounds | 1 | 2017 | 75 | 0.16 | Why? |
| Quaternary Ammonium Compounds | 1 | 2017 | 136 | 0.16 | Why? |
| Sensitivity and Specificity | 9 | 2021 | 22971 | 0.16 | Why? |
| Molecular Sequence Data | 5 | 2012 | 3198 | 0.16 | Why? |
| Trachea | 1 | 2021 | 894 | 0.16 | Why? |
| RNA | 2 | 2021 | 1278 | 0.16 | Why? |
| Vitreous Body | 1 | 2017 | 161 | 0.16 | Why? |
| Base Sequence | 3 | 2017 | 3581 | 0.15 | Why? |
| Lymphoma, B-Cell | 1 | 2017 | 166 | 0.15 | Why? |
| Erythrocytes | 2 | 2018 | 617 | 0.15 | Why? |
| Interferon Regulatory Factor-3 | 1 | 2018 | 379 | 0.15 | Why? |
| Dental Caries | 1 | 2017 | 163 | 0.14 | Why? |
| Herpesvirus 3, Human | 1 | 2017 | 228 | 0.14 | Why? |
| Candidiasis | 1 | 2019 | 334 | 0.14 | Why? |
| Endoplasmic Reticulum | 1 | 2018 | 430 | 0.14 | Why? |
| Rectal Neoplasms | 1 | 2019 | 278 | 0.14 | Why? |
| Water Microbiology | 1 | 2017 | 248 | 0.14 | Why? |
| Candida | 1 | 2019 | 425 | 0.14 | Why? |
| Databases, Genetic | 1 | 2020 | 1127 | 0.14 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.14 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.13 | Why? |
| RNA, Messenger | 3 | 2018 | 5131 | 0.13 | Why? |
| Plasmids | 1 | 2017 | 840 | 0.13 | Why? |
| Herpes Simplex | 1 | 2017 | 272 | 0.13 | Why? |
| Microarray Analysis | 2 | 2012 | 262 | 0.13 | Why? |
| Polymerase Chain Reaction | 8 | 2017 | 6740 | 0.13 | Why? |
| Cell Phone | 1 | 2020 | 750 | 0.12 | Why? |
| Humans | 41 | 2022 | 930598 | 0.12 | Why? |
| Nicaragua | 1 | 2012 | 71 | 0.12 | Why? |
| Urinary Tract Infections | 1 | 2018 | 534 | 0.12 | Why? |
| Candida albicans | 1 | 2013 | 217 | 0.12 | Why? |
| Cytomegalovirus | 1 | 2017 | 600 | 0.11 | Why? |
| Tissue Donors | 1 | 2021 | 1679 | 0.11 | Why? |
| Gene Expression | 2 | 2020 | 3332 | 0.11 | Why? |
| Transcription Factors | 1 | 2017 | 784 | 0.11 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1014 | 0.11 | Why? |
| Tropical Climate | 1 | 2012 | 179 | 0.11 | Why? |
| Workflow | 1 | 2020 | 2373 | 0.11 | Why? |
| Cytomegalovirus Infections | 1 | 2017 | 667 | 0.10 | Why? |
| Reagent Kits, Diagnostic | 1 | 2021 | 2149 | 0.10 | Why? |
| Serum | 1 | 2012 | 294 | 0.10 | Why? |
| Rituximab | 1 | 2018 | 1096 | 0.10 | Why? |
| Genetic Vectors | 1 | 2017 | 1600 | 0.10 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.10 | Why? |
| Amino Acid Sequence | 3 | 2017 | 6049 | 0.10 | Why? |
| Poliovirus | 1 | 2009 | 109 | 0.09 | Why? |
| Computational Biology | 3 | 2014 | 4514 | 0.09 | Why? |
| Antifungal Agents | 1 | 2019 | 1828 | 0.09 | Why? |
| Nuclear Proteins | 2 | 2017 | 321 | 0.09 | Why? |
| Delirium | 1 | 2018 | 1061 | 0.09 | Why? |
| Gene Regulatory Networks | 1 | 2013 | 820 | 0.09 | Why? |
| Animals | 10 | 2020 | 78931 | 0.09 | Why? |
| Nucleotides | 1 | 2009 | 212 | 0.08 | Why? |
| Male | 17 | 2021 | 367725 | 0.08 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2020 | 3607 | 0.08 | Why? |
| Transcriptome | 2 | 2017 | 3466 | 0.08 | Why? |
| Virus Replication | 2 | 2018 | 14331 | 0.08 | Why? |
| HeLa Cells | 1 | 2009 | 1303 | 0.07 | Why? |
| RNA Interference | 2 | 2020 | 534 | 0.07 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.07 | Why? |
| Asymptomatic Infections | 2 | 2021 | 7218 | 0.07 | Why? |
| Genome, Fungal | 1 | 2004 | 26 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.07 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.07 | Why? |
| Chromosome Mapping | 1 | 2004 | 178 | 0.07 | Why? |
| Genomics | 2 | 2022 | 3118 | 0.07 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2011 | 595 | 0.07 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.07 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.07 | Why? |
| Fungal Proteins | 1 | 2004 | 133 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Phylogeny | 7 | 2020 | 13341 | 0.06 | Why? |
| Sepsis | 1 | 2020 | 3517 | 0.06 | Why? |
| Adult | 10 | 2021 | 244371 | 0.06 | Why? |
| Saccharomyces cerevisiae | 1 | 2004 | 339 | 0.06 | Why? |
| Ribavirin | 1 | 2009 | 1182 | 0.06 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.06 | Why? |
| Cell Cycle Proteins | 1 | 2004 | 297 | 0.06 | Why? |
| Respiratory Tract Infections | 4 | 2020 | 6817 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Female | 13 | 2021 | 380317 | 0.06 | Why? |
| Rhinovirus | 1 | 2007 | 979 | 0.05 | Why? |
| Fever | 1 | 2018 | 7795 | 0.05 | Why? |
| Madagascar | 1 | 2021 | 197 | 0.05 | Why? |
| Asthma | 2 | 2018 | 4383 | 0.05 | Why? |
| Chromatin Immunoprecipitation | 2 | 2013 | 53 | 0.05 | Why? |
| Sequence Analysis, RNA | 2 | 2021 | 2290 | 0.05 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.05 | Why? |
| Child | 4 | 2021 | 70012 | 0.05 | Why? |
| Anesthetics, Dissociative | 1 | 2018 | 21 | 0.05 | Why? |
| Aged | 6 | 2021 | 215776 | 0.05 | Why? |
| Fatal Outcome | 2 | 2019 | 3438 | 0.05 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Genome, Mitochondrial | 1 | 2017 | 14 | 0.05 | Why? |
| Fluconazole | 1 | 2019 | 145 | 0.05 | Why? |
| Echinocandins | 1 | 2019 | 139 | 0.05 | Why? |
| Dental Plaque | 1 | 2017 | 13 | 0.04 | Why? |
| Vision, Ocular | 1 | 2017 | 37 | 0.04 | Why? |
| Protein Array Analysis | 1 | 2020 | 387 | 0.04 | Why? |
| Patient Harm | 1 | 2017 | 14 | 0.04 | Why? |
| Promoter Regions, Genetic | 2 | 2017 | 823 | 0.04 | Why? |
| Trophozoites | 1 | 2017 | 13 | 0.04 | Why? |
| Plasmodium berghei | 1 | 2017 | 27 | 0.04 | Why? |
| Chromatin Assembly and Disassembly | 1 | 2017 | 62 | 0.04 | Why? |
| Peptide Library | 1 | 2020 | 564 | 0.04 | Why? |
| Genotype | 1 | 2009 | 4697 | 0.04 | Why? |
| Foot-and-Mouth Disease | 1 | 2017 | 35 | 0.04 | Why? |
| Oregon | 1 | 2017 | 224 | 0.04 | Why? |
| Protein Binding | 4 | 2017 | 11430 | 0.04 | Why? |
| Gene Expression Profiling | 2 | 2021 | 3788 | 0.04 | Why? |
| Genome, Viral | 3 | 2021 | 13157 | 0.04 | Why? |
| In Situ Hybridization | 1 | 2017 | 390 | 0.04 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.04 | Why? |
| Injections, Intramuscular | 1 | 2018 | 800 | 0.04 | Why? |
| DNA Helicases | 1 | 2017 | 203 | 0.04 | Why? |
| Molecular Sequence Annotation | 1 | 2017 | 478 | 0.04 | Why? |
| SARS Virus | 3 | 2003 | 13021 | 0.04 | Why? |
| Cell Line | 3 | 2020 | 12040 | 0.04 | Why? |
| Light | 1 | 2017 | 306 | 0.04 | Why? |
| DNA Mutational Analysis | 1 | 2017 | 581 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Birds | 1 | 2017 | 412 | 0.03 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.03 | Why? |
| Cell Nucleus | 1 | 2017 | 399 | 0.03 | Why? |
| Sequence Homology, Amino Acid | 1 | 2017 | 945 | 0.03 | Why? |
| DNA, Fungal | 1 | 2013 | 95 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2020 | 1706 | 0.03 | Why? |
| Gene Editing | 1 | 2017 | 330 | 0.03 | Why? |
| Respiration | 1 | 2018 | 729 | 0.03 | Why? |
| Viral Proteins | 2 | 2020 | 7370 | 0.03 | Why? |
| Protein Structure, Secondary | 1 | 2017 | 1077 | 0.03 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.03 | Why? |
| Models, Statistical | 1 | 2009 | 5312 | 0.03 | Why? |
| Microfluidics | 1 | 2013 | 171 | 0.03 | Why? |
| Sentinel Surveillance | 1 | 2019 | 1093 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Databases, Nucleic Acid | 1 | 2014 | 272 | 0.03 | Why? |
| Eosinophils | 1 | 2018 | 848 | 0.03 | Why? |
| Infant | 2 | 2012 | 30274 | 0.03 | Why? |
| Severe Acute Respiratory Syndrome | 3 | 2003 | 12361 | 0.03 | Why? |
| Travel | 2 | 2021 | 7220 | 0.03 | Why? |
| Mass Spectrometry | 1 | 2017 | 1165 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2020 | 11304 | 0.03 | Why? |
| Torque teno virus | 1 | 2011 | 73 | 0.03 | Why? |
| Sequence Alignment | 1 | 2017 | 2109 | 0.03 | Why? |
| DNA Virus Infections | 1 | 2011 | 88 | 0.03 | Why? |
| Catalytic Domain | 1 | 2017 | 1757 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2019 | 2886 | 0.03 | Why? |
| Proteome | 1 | 2020 | 1812 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2017 | 2134 | 0.02 | Why? |
| Heart Rate | 1 | 2018 | 1527 | 0.02 | Why? |
| Communicable Diseases, Emerging | 1 | 2003 | 2523 | 0.02 | Why? |
| Cricetinae | 1 | 2017 | 3344 | 0.02 | Why? |
| Interferon-alpha | 1 | 2017 | 1442 | 0.02 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.02 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2011 | 2309 | 0.02 | Why? |
| Nasal Lavage Fluid | 1 | 2007 | 43 | 0.02 | Why? |
| Swine | 1 | 2017 | 3352 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2021 | 3493 | 0.02 | Why? |
| Transcription, Genetic | 2 | 2004 | 1326 | 0.02 | Why? |
| Epigenesis, Genetic | 1 | 2013 | 711 | 0.02 | Why? |
| Malaria | 1 | 2017 | 1097 | 0.02 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.02 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2017 | 3239 | 0.02 | Why? |
| Chromosomes, Fungal | 1 | 2004 | 2 | 0.02 | Why? |
| Nocodazole | 1 | 2004 | 12 | 0.02 | Why? |
| Chromosomes, Artificial, Yeast | 1 | 2004 | 31 | 0.02 | Why? |
| Meiosis | 1 | 2004 | 12 | 0.02 | Why? |
| Chromosomal Proteins, Non-Histone | 1 | 2004 | 33 | 0.02 | Why? |
| Mitosis | 1 | 2004 | 43 | 0.02 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
| Galactose | 1 | 2004 | 201 | 0.02 | Why? |
| Virus Cultivation | 1 | 2007 | 579 | 0.02 | Why? |
| Biodiversity | 1 | 2007 | 546 | 0.02 | Why? |
| Regulatory Sequences, Nucleic Acid | 1 | 2003 | 95 | 0.02 | Why? |
| HEK293 Cells | 1 | 2017 | 8394 | 0.02 | Why? |
| Phenotype | 1 | 2013 | 4037 | 0.01 | Why? |
| Models, Genetic | 1 | 2004 | 434 | 0.01 | Why? |
| ROC Curve | 1 | 2014 | 6024 | 0.01 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.01 | Why? |
| India | 1 | 2019 | 11875 | 0.01 | Why? |
| Molecular Docking Simulation | 1 | 2017 | 6902 | 0.01 | Why? |
| DNA, Complementary | 1 | 2003 | 568 | 0.01 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.01 | Why? |
| Conserved Sequence | 1 | 2003 | 751 | 0.01 | Why? |
| Microscopy, Electron | 1 | 2003 | 830 | 0.01 | Why? |
| Coronavirus | 2 | 2007 | 18339 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Polyproteins | 1 | 2003 | 814 | 0.01 | Why? |
| Incidence | 1 | 2022 | 25622 | 0.01 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| DNA | 1 | 2004 | 778 | 0.01 | Why? |
| Acute Disease | 1 | 2011 | 6029 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Models, Biological | 1 | 2013 | 4907 | 0.01 | Why? |
| Open Reading Frames | 1 | 2003 | 1898 | 0.01 | Why? |
| Viral Matrix Proteins | 1 | 2003 | 1243 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2003 | 27595 | 0.01 | Why? |
| Oropharynx | 1 | 2003 | 1581 | 0.01 | Why? |
| Membrane Glycoproteins | 1 | 2003 | 2273 | 0.01 | Why? |
| Cells, Cultured | 1 | 2004 | 5835 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2008 | 9537 | 0.01 | Why? |
| Pediatrics | 1 | 2008 | 2969 | 0.01 | Why? |
| Binding Sites | 1 | 2004 | 6201 | 0.01 | Why? |
| Molecular Diagnostic Techniques | 1 | 2008 | 4239 | 0.01 | Why? |
| Nucleocapsid Proteins | 1 | 2003 | 3120 | 0.01 | Why? |
| Viral Envelope Proteins | 1 | 2003 | 3539 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.01 | Why? |
| Lung | 1 | 2003 | 31049 | 0.00 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2003 | 37182 | 0.00 | Why? |